cchase on PROD1PC60 with NOTICES

29336 Federal Register / Vol. 71, No. 98 / Monday, May 22, 2006 / Notices 

in households at high risk for fire and 

fire-related injury and death. Programs 

of this type are thought to prevent firerelated injury and mortality, but have 

not been studied scientifically to assess 

their impact on fire-related injury 

outcomes. The proposed study 

represents the first formal effort to 

evaluate the effectiveness and cost 

implications of the SAIFE program as 

implemented in North Carolina. The 

data collected in this study will have 

the potential to impact other smoke 

alarm installation programs, as well as 

ESTIMATED ANNUALIZED BURDEN HOURS 

indicate future priorities in prevention 

and preparedness for residential fires. 

There are no costs to the respondents 

other than their time. The total 

estimated annualized burden hours are 

251. 

Respondents No. of respondents 

No. of responses per 

respondent 

Average burden per response 

(in hours). 

Adult male and female (age 18+ years) screened ...................................................................... 

Adult male and female (age 18+ years) Pre/Post Evaluation survey ......................................... 

Adult male and female (age 18+ years) household visit ............................................................. 

425 

360 

36 

1 

2 

1 

5/60 

15/60 

1 

Dated: May 8, 2006. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E6–7732 Filed 5–19–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Decision To Evaluate a Petition To 

Designate a Class of Employees at 

Monsanto Chemical Company, Dayton, 

Ohio, To Be included in the Special 

Exposure Cohort 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice as 

required by 42 CFR 83.12(e) of a 

decision to evaluate a petition to 

designate a class of employees at 

Monsanto Chemical Company, Dayton, 

Ohio, to be included in the Special 

Exposure Cohort under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. The 

initial proposed definition for the class 

being evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Monsanto Chemical 

Company. 

Location: Dayton, Ohio. Job Titles and/or Job Duties: Directors 

and subordinates, physicists, chemists, 

technicians, and workers. 

Period of Employment: 1943–1949. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. E6–7777 Filed 5–19–06; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Privacy Act of 1974; Report of a New 

System of Records 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice of a New System of 

Records (SOR). 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974, 

we are proposing to establish a new 

SOR titled, ‘‘Organ Procurement 

Organizations System (OPOS), System 

No. 09–70–0575.’’ The Organ 

Procurement Organization (OPO) 

Certification Act of 2000 (§ 701 of Pub. 

L. 106–505) directs the Secretary of HHS 

to establish regulations that provide the 

statutory qualifications and 

requirements that an OPO must meet in 

order for organ procurement costs to be 

reimbursed under the Medicare and 

Medicaid programs. As part of the 

efficient administration of this program, 

CMS is charged with the responsibility 

to conduct investigations, analysis, and 

reporting of adverse events that are 

described as an untoward, undesirable, 

and unanticipated event that causes 

death or serious injury. At this time, 

individually-identifiable data is only 

requested from OPOs under two 

circumstances: (1) Due to the suspicion 

that an infectious disease has been 

transmitted to a recipient; and (2) when 

there has been a complaint alleged 

against an OPO. CMS regional office 

survey and certification staff would 

request individually-identifiable data to 

complete the investigation. Due to 

certain investigatory activities related to 

this system, CMS proposes to exempt 

this system from the notification, access, 

correction and amendment provisions of 

the Privacy Act of 1974. 

The purpose of this system is to 

collect and maintain individually 

identifiable information pertaining to 

complaint allegations filed by a 

complainant, beneficiary, or providers 

of services made against OPOs, 

information gathered during the 

complaint investigation, findings and 

results of the investigation, and 

correspondence relating to the outcome 

of the investigation. Information 

retrieved from this system will also be 

disclosed to: (1) Support regulatory, 

reimbursement, and policy functions 

performed within the agency, or by a 

contractor, consultant or grantee; (2) 

assist another Federal or state agency in 

the enforcement of OPO regulations 

where sharing the information is 

necessary to complete the processing of 

a complaint, contribute to the accuracy 

of CMS’s proper payment of Medicare 

benefits, and/or enable such agency to 

administer a Federal health benefits 

program; (3) support constituent 

requests made to a Congressional 

representative; and (4) support litigation 

involving the agency. We have provided 

background information about the 

modified system in the ‘‘Supplementary 

Information’’ section below. Although 

the Privacy Act requires only that CMS 

provide an opportunity for interested 

persons to comment on the proposed 

routine uses, CMS invites comments on 

all portions of this notice. See ‘‘Effective 

Dates’’ section for comment period. 

DATES: Effective Date: CMS filed a new 

SOR report with the Chair of the House